Trial Outcomes & Findings for Standardized Versus Tailored Implementation of Measurement Based Care for Depression (NCT NCT02266134)

NCT ID: NCT02266134

Last Updated: 2023-06-02

Results Overview

Patient Health Questionnaire-9 (PHQ-9): screening tool for depression that can be used to monitor symptom change over time and inform care. Minimum value: 0 Maximum value: 27 Higher scores indicate a greater severity of depression (i.e., worse outcome).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

382 participants

Primary outcome timeframe

Week 0 (baseline) and Week 12 of treatment

Results posted on

2023-06-02

Participant Flow

12 community-based behavioral health clinics were randomized into four groups: (1) Sites 1-2; (2) Sites 3-6; (3) Sites 7-10; and (4) Sites 11-12. Therapist recruitment was in-person or via email from June 3, 2015-October 18, 2016. Patient recruitment was staggered such that each site began recruitment approximately five months apart. Recruitment start dates: (1) Sites 1-2: August 13, 2015; Sites 3-6: December 7, 2015; Sites 7-10: May 20, 2016; and Sites 11-12: December 2, 2016.

Of the 2459 patients assessed for eligibility, 228 met inclusion criteria and were enrolled during the study's active implementation window (0-5 months). Of the 525 therapists assessed for eligibility, 154 met inclusion criteria and consented during the study's active implementation window (0-5 months).

Unit of analysis: Health Clinics

Participant milestones

Participant milestones
Measure
Standardized Implementation, Patients
Sites in the standardized condition arm will receive the standard implementation of measurement-based care intervention (PHQ-9).
Tailored Implementation, Patients
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic.
Standardized Implementation, Therapists
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client, and they will work as a team to maximize fidelity.
Tailored Condition, Therapists
Sites in the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement-based care to tailored clinic.
Clinics #1-2: Beginning Aug 2015
STARTED
9 1
11 1
14 1
14 1
Clinics #1-2: Beginning Aug 2015
COMPLETED
3 1
8 1
14 1
14 1
Clinics #1-2: Beginning Aug 2015
NOT COMPLETED
6 0
3 0
0 0
0 0
Clinics #3-6: Beginning Dec 2015
STARTED
47 2
24 2
14 2
17 2
Clinics #3-6: Beginning Dec 2015
COMPLETED
39 2
22 2
14 2
17 2
Clinics #3-6: Beginning Dec 2015
NOT COMPLETED
8 0
2 0
0 0
0 0
Clinics #7-10: Beginning May 2016
STARTED
39 2
33 2
28 2
29 2
Clinics #7-10: Beginning May 2016
COMPLETED
26 2
28 2
28 2
29 2
Clinics #7-10: Beginning May 2016
NOT COMPLETED
13 0
5 0
0 0
0 0
Clinics #11-12: Beginning Dec 2016
STARTED
46 1
19 1
15 1
23 1
Clinics #11-12: Beginning Dec 2016
COMPLETED
37 1
17 1
15 1
23 1
Clinics #11-12: Beginning Dec 2016
NOT COMPLETED
9 0
2 0
0 0
0 0

Reasons for withdrawal

Reasons for withdrawal
Measure
Standardized Implementation, Patients
Sites in the standardized condition arm will receive the standard implementation of measurement-based care intervention (PHQ-9).
Tailored Implementation, Patients
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic.
Standardized Implementation, Therapists
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client, and they will work as a team to maximize fidelity.
Tailored Condition, Therapists
Sites in the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement-based care to tailored clinic.
Clinics #1-2: Beginning Aug 2015
Lost to Follow-up
6
3
0
0
Clinics #3-6: Beginning Dec 2015
Lost to Follow-up
8
2
0
0
Clinics #7-10: Beginning May 2016
Lost to Follow-up
10
5
0
0
Clinics #7-10: Beginning May 2016
Withdrawal by Subject
3
0
0
0
Clinics #11-12: Beginning Dec 2016
Lost to Follow-up
6
2
0
0
Clinics #11-12: Beginning Dec 2016
Withdrawal by Subject
3
0
0
0

Baseline Characteristics

Standardized Versus Tailored Implementation of Measurement Based Care for Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standardized Implementation, Patients
n=141 Participants
Sites in this arm will receive the standard implementation of measurement based care intervention. Standard Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire (PHQ-9), the implementation of measurement based care will be standardized such that clinicians will be encouraged to administer the PHQ-9 to depressed clients before each session.
Tailored Implementation, Patients
n=87 Participants
Sites in this arm will receive the tailored implementation of measurement based care intervention. Tailored Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire, the implementation of measurement based care will be tailored based on clinic specific barriers and facilitators.
Standardized Implementation, Therapists
n=71 Participants
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client and they will work as a team to maximize fidelity.
Tailored Implementation, Therapists
n=83 Participants
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic.
Total
n=382 Participants
Total of all reporting groups
Age, Continuous
42.06 years
STANDARD_DEVIATION 11.48 • n=5 Participants
40.14 years
STANDARD_DEVIATION 11.74 • n=7 Participants
45.23 years
STANDARD_DEVIATION 14.07 • n=5 Participants
41.99 years
STANDARD_DEVIATION 13.22 • n=4 Participants
41.32 years
STANDARD_DEVIATION 12.36 • n=21 Participants
Sex/Gender, Customized
Gender Identity · Female
96 Participants
n=5 Participants
61 Participants
n=7 Participants
54 Participants
n=5 Participants
67 Participants
n=4 Participants
278 Participants
n=21 Participants
Sex/Gender, Customized
Gender Identity · Male
44 Participants
n=5 Participants
26 Participants
n=7 Participants
17 Participants
n=5 Participants
15 Participants
n=4 Participants
102 Participants
n=21 Participants
Sex/Gender, Customized
Gender Identity · Transgender
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
1 Participants
n=21 Participants
Sex/Gender, Customized
Gender Identity · Non-binary
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Sex/Gender, Customized
Gender Identity · Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
13 Participants
n=5 Participants
15 Participants
n=7 Participants
3 Participants
n=5 Participants
0 Participants
n=4 Participants
31 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
127 Participants
n=5 Participants
70 Participants
n=7 Participants
67 Participants
n=5 Participants
83 Participants
n=4 Participants
347 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
2 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
4 Participants
n=21 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
3 Participants
n=7 Participants
2 Participants
n=5 Participants
0 Participants
n=4 Participants
6 Participants
n=21 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Race (NIH/OMB)
Black or African American
22 Participants
n=5 Participants
6 Participants
n=7 Participants
10 Participants
n=5 Participants
8 Participants
n=4 Participants
46 Participants
n=21 Participants
Race (NIH/OMB)
White
105 Participants
n=5 Participants
65 Participants
n=7 Participants
55 Participants
n=5 Participants
74 Participants
n=4 Participants
299 Participants
n=21 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
1 Participants
n=4 Participants
6 Participants
n=21 Participants
Race (NIH/OMB)
Unknown or Not Reported
11 Participants
n=5 Participants
12 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
24 Participants
n=21 Participants
Region of Enrollment
United States
141 participants
n=5 Participants
87 participants
n=7 Participants
71 participants
n=5 Participants
83 participants
n=4 Participants
382 participants
n=21 Participants
Highest Education Status
Some high school
26 Participants
n=5 Participants
8 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
34 Participants
n=21 Participants
Highest Education Status
High school diploma or equivalent
54 Participants
n=5 Participants
30 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
84 Participants
n=21 Participants
Highest Education Status
Some college, but no degree
34 Participants
n=5 Participants
35 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
69 Participants
n=21 Participants
Highest Education Status
Associate's degree
9 Participants
n=5 Participants
5 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
14 Participants
n=21 Participants
Highest Education Status
Bachelor's degree
8 Participants
n=5 Participants
4 Participants
n=7 Participants
2 Participants
n=5 Participants
2 Participants
n=4 Participants
16 Participants
n=21 Participants
Highest Education Status
Master's degree
2 Participants
n=5 Participants
1 Participants
n=7 Participants
66 Participants
n=5 Participants
79 Participants
n=4 Participants
148 Participants
n=21 Participants
Highest Education Status
Doctoral degree or equivalent
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
1 Participants
n=4 Participants
5 Participants
n=21 Participants
Highest Education Status
Other
6 Participants
n=5 Participants
4 Participants
n=7 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
11 Participants
n=21 Participants
Highest Education Status
Missing or not reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
1 Participants
n=21 Participants

PRIMARY outcome

Timeframe: Week 0 (baseline) and Week 12 of treatment

Population: In the standardized implementation condition, 141 patients provided baseline data and 102/141 participants provided 12-week data. In the tailored implementation condition, 87 patients provided baseline data and 74/87 provided 12-week data.

Patient Health Questionnaire-9 (PHQ-9): screening tool for depression that can be used to monitor symptom change over time and inform care. Minimum value: 0 Maximum value: 27 Higher scores indicate a greater severity of depression (i.e., worse outcome).

Outcome measures

Outcome measures
Measure
Standardized Implementation
n=141 Participants
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client and they will work as a team to maximize fidelity. Sites in this arm will receive the standard implementation of measurement based care intervention. Standard Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire (PHQ-9), the implementation of measurement based care will be standardized such that clinicians will be encouraged to administer the PHQ-9 to depressed clients before each session.
Tailored Implementation
n=87 Participants
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic. Sites in this arm will receive the tailored implementation of measurement based care intervention. Tailored Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire, the implementation of measurement based care will be tailored based on clinic specific barriers and facilitators.
Patient Health Questionnaire
12-Week
12.15 score on a scale
Standard Deviation 6.07
13.09 score on a scale
Standard Deviation 5.76
Patient Health Questionnaire
Baseline
18.04 score on a scale
Standard Deviation 4.10
16.77 score on a scale
Standard Deviation 4.73

PRIMARY outcome

Timeframe: 5-month implementation window

Population: For each participating therapist, the raw counts of fidelity (scored as 1, 2, or 3) are included at the session-level for the 15,686 individual psychotherapy sessions.

PHQ-9 fidelity was monitored for each individual psychotherapy session. Fidelity was scored as: (1) Therapist did not complete or record any PHQ-9 scores; (2) Therapist completed PHQ-9 and recorded scores in the EHR only; or (3) Therapist completed PHQ-9, recorded scores in the EHR, and discussed scores with the patient. The unit of measure is the number individual psychotherapy sessions conducted during the 5-month implementation window. Patient data were included for any patient at least 18 years old at the time of their first session with a participating therapist, regardless of if the patient was enrolled in the study.

Outcome measures

Outcome measures
Measure
Standardized Implementation
n=7570 Individual psychotherapy sessions
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client and they will work as a team to maximize fidelity. Sites in this arm will receive the standard implementation of measurement based care intervention. Standard Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire (PHQ-9), the implementation of measurement based care will be standardized such that clinicians will be encouraged to administer the PHQ-9 to depressed clients before each session.
Tailored Implementation
n=8116 Individual psychotherapy sessions
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic. Sites in this arm will receive the tailored implementation of measurement based care intervention. Tailored Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire, the implementation of measurement based care will be tailored based on clinic specific barriers and facilitators.
PHQ-9 Completed Fidelity
1. PHQ-9 Not Completed
4894 Individual psychotherapy sessions
5270 Individual psychotherapy sessions
PHQ-9 Completed Fidelity
2. PHQ-9 Completed (Reported in EHR) Only
1564 Individual psychotherapy sessions
860 Individual psychotherapy sessions
PHQ-9 Completed Fidelity
3. PHQ-9 Completed and Discussed with Patient
1112 Individual psychotherapy sessions
1986 Individual psychotherapy sessions

Adverse Events

Standardized Implementation, Patients

Serious events: 5 serious events
Other events: 0 other events
Deaths: 0 deaths

Tailored Implementation, Patients

Serious events: 8 serious events
Other events: 1 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Standardized Implementation, Patients
n=141 participants at risk
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client and they will work as a team to maximize fidelity. Sites in this arm will receive the standard implementation of measurement based care intervention. Standard Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire (PHQ-9), the implementation of measurement based care will be standardized such that clinicians will be encouraged to administer the PHQ-9 to depressed clients before each session
Tailored Implementation, Patients
n=87 participants at risk
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic. Sites in this arm will receive the tailored implementation of measurement based care intervention. Tailored Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire, the implementation of measurement based care will be tailored based on clinic specific barriers and facilitators
Psychiatric disorders
Suicidal Ideation
3.5%
5/141 • Number of events 5 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
8.0%
7/87 • Number of events 7 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
Psychiatric disorders
Medical Hospitalization
0.00%
0/141 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
0.00%
0/87 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
Psychiatric disorders
Death
0.00%
0/141 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
1.1%
1/87 • Number of events 1 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.

Other adverse events

Other adverse events
Measure
Standardized Implementation, Patients
n=141 participants at risk
Sites randomized to the standardized condition will be expected to use the Patient Health Questionnaire prior to each session with a depressed client and they will work as a team to maximize fidelity. Sites in this arm will receive the standard implementation of measurement based care intervention. Standard Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire (PHQ-9), the implementation of measurement based care will be standardized such that clinicians will be encouraged to administer the PHQ-9 to depressed clients before each session
Tailored Implementation, Patients
n=87 participants at risk
Sites randomized to the tailored condition will develop a site-specific protocol for use of the Patient Health Questionnaire and they will work as a team to maximize the fit of measurement based care to this clinic. Sites in this arm will receive the tailored implementation of measurement based care intervention. Tailored Implementation of Measurement Based Care: measurement based care in this study is the practice of basing psychotherapeutic services on the results of the Patient Health Questionnaire, the implementation of measurement based care will be tailored based on clinic specific barriers and facilitators
Psychiatric disorders
Inappropriate Behavior Toward Staff
0.00%
0/141 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.
1.1%
1/87 • Number of events 1 • Collected during a client's enrollment in the study (i.e., approximately 12 weeks).
Adverse events were only tracked and assessed for patients, not therapists. This was because, to the best of our knowledge, therapists were not likely to experience adverse events, as they were only making changes to their routine clinical practice. Patients, however, all had a depression diagnosis, were receiving clinical care, and were more sensitive to adverse events, such as medical hospitalization, suicidal ideation, or death.

Additional Information

Dr. Cara C. Lewis

Kaiser Permanente Washington Health Research Institute

Phone: 206-422-4076

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place